-
-
-
-
-
-
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $510 at H.C. Wainwright
-
-
-
-
-
-
-
RBC Capital on Alnylam Pharmaceuticals (ALNY): '2026 Guide Meaningfully Ahead Of Consensus'
-
-
-
-
-
-
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $508 at Stifel on Vutrisiran Success
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Alnylam Pharmaceuticals (ALNY) at Neutral on Good Execution
-
-
-
-
-
-
-
Alnylam joins Alliance for Genomic Discovery genomic dataset
-
-
-
-
-
-
-
Truist Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) Ahead of ESC Data Presentation
-
-
-
-
-
-
-
Alnylam Pharma (ALNY) Tops Q2 EPS by 91c
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

